Aesthetics Treatments

Profhilo

What is PROFHILO®

The first revolutionary bio remodelling “injectable skincare” that addresses skin laxity and signs of aging through the bio-stimulation of collagen, elastin and adipocytes (fats) stem cells that were lost through skin aging

New anti-aging approach with innovative technology that targets from the inside out
Uses 100% pure hyaluronic acid
High hyaluronic concentration using 32mg of hyaluronic acid (high molecular weight) and 32mg of hyaluronic acid (low molecular weight)
Intervenes the process of aging tissue, biostimulates elastin and collagen
Addresses signs of skin aging naturally

SUGGESTED TREATMENT PROTOCOL

1st

treatment

1
month apart

2nd

treatment

6 – 9
month apart

Repeat Protocol

for maintenance

*3rd treatment after 2 months may be required depending on skin laxity

Why PROFHILO®

Formulated with unique patented NAHYCO® Hybrid Technology
Clinically proven for safety, efficacy and bio - compatibility
Sustainable results without use of chemical cross - linking agents, reducing chances of inflammation
Reaches multiple skin layers, targeting skin laxity and loss of collagen
Unique BAP (Bio Aesthetic Points) injection technique for optimal diffusion of the product

With just 5 BAP injection points per side of the face, Profhilo diffuses through the different skin layers, across the widest sections of the face through, bringing a natural and lasting refreshed look.

The 10 BAP injection points for neck is carefully developed to avoid injury to vital structures, providing anti-aging benefits from the inside out.

BENEFITS PROFHILO®

Bio-stimulates elastin, 4 types of collagen and hydration in the 3 main layers of the skin
Provides firming, tightening and lifting effect to the skin
Improves overall skin quality and hydration
Fast and effective treatment with minimal pain and downtime
Provides tissue repair process, ideal for acne scarring

References:

1 Stellavato, A. et al. ‘Hyaluronan Hybrid Cooperative Complexes as a Novel Frontier for Cellular Bioprocesses Re-Activation’. PLOS ONE, 11(10) (2016), e0163510.

2 Laurino, C. et al. ‘Efficacy, Safety, and Tolerance of a new Injection Technique for High- and Low-Molecular-Weight Hyaluronic Acid Hybrid Complexes’. An Open

Access Journal, 15 (2015), 427-437.